$CTS

CTS CORP

AlphAI earnings readThird quarter 2026 · OCT 272026 Outlook Raised on Record Profitability; Millar Acquisition Advances DiversificationVerdict: strong

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

15
3
0

No SEC Form 4 filings for $CTS in the last 30 days.

See all $CTS insider activity →
High

CTS Q3 2026 slides: record margins fuel guidance raise

CTS Corporation (NYSE:CTS) reported Q3 2026 earnings of $0.77 per share on revenue of $149.6M, beating estimates. Adjusted gross margin hit a record 42.2%. The company raised full-year guidance, citing strong demand and diversification. Shares rose 5.42% premarket. CTS acquired Millar to expand into medical and industrial sensing.

CTS Announces Third Quarter 2026 Results

CTS CORP (CTS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 October 27, 2026 FOR IMMEDIATE RELEASE CTS Announces Third Quarter 2026 Results 2026 Outlook Raised on Record Profitability; Millar Acquisition Advances Diversification Lisle, Ill. - CTS Corporation (NYSE: CTS), a leading global designer and manufacturer of highly en

CTS sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 18 news stories mentioning CTS (CTS CORP). Coverage has skewed bullish: 15 bullish, 3 neutral, and 0 bearish.

Recent CTS coverage spans earnings, financial news and technology.

What's driving CTS

AlphAI scores every news story that mentions CTS with an AI model for sentiment and relevance, and aggregates insider trades from CTS CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $CTS

Score
$CTSHighAI 8/10

CTS Q3 2026 slides: record margins fuel guidance raise

CTS Corporation (NYSE:CTS) reported Q3 2026 earnings of $0.77 per share on revenue of $149.6M, beating estimates. Adjusted gross margin hit a record 42.2%. The company raised full-year guidance, citing strong demand and diversification. Shares rose 5.42% premarket. CTS acquired Millar to expand into medical and industrial sensing.

$CTSHigh

CTS Announces Third Quarter 2026 Results

CTS CORP (CTS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 October 27, 2026 FOR IMMEDIATE RELEASE CTS Announces Third Quarter 2026 Results 2026 Outlook Raised on Record Profitability; Millar Acquisition Advances Diversification Lisle, Ill. - CTS Corporation (NYSE: CTS), a leading global designer and manufacturer of highly en

CTS Introduces Its First Digital Temperature Sensor Platform, Expanding Smart Sensing Capabilities

CTS Corporation (NYSE: CTS) launched its first Digital Temperature Sensor platform, expanding its temperature sensing portfolio. The platform offers high-accuracy digital sensing for industrial, medical, transportation, and electronics applications, with flexible configurations and simplified integration. According to CTS, this strengthens its support for customers throughout product development.

$CTSMed

CTS (CTS) Could Be 13% Undervalued Following Its Distribution Expansion

CTS Corp. (CTS) announced its sensing solutions will now be sold through authorized distribution partners, targeting non-automotive, high-growth markets. Shares have declined 11.77% over 30 days but are up 29.01% year-to-date. Analysts suggest the stock may be 13% undervalued at $56.57, with a fair value estimate of $65, citing future earnings growth and margin expansion. However, the company faces challenges from weaker transportation demand and competitive pressures in Europe.

CTS Corporation (CTS) Stock Forecasts

Argus on Aug 12, 2026 lowered its target price for CTS Corp (CTS) to $72.00. The note describes CTS Corp as an electronics manufacturer of sensors, electronic components, and actuators. Other listed items include target or rating changes for APH, IPGP, ESE, AGYS, and LFUS.

The 5 Most Interesting Analyst Questions From CTS’s Q2 Earnings Call

CTS (CTS) reported Q2 results with management citing growth in medical, industrial, and aerospace/defense, plus operational improvements and a more profitable sales mix. It noted modest transportation declines and one-time items that boosted EPS. Analysts asked about CEO strategy, R&D recurrence, medical margins, pricing and cost inflation, and transportation outlook. CTS shares were about $65.25 after earnings.

Related tickers